Gelsomino, Francesco; Boni, Luca; Tiseo, Marcello; Ricciardi, Serena; Rocco, Danilo; Cortinovis, Diego L; Proietto, Manuela; Cogoni, Alessio; Pasello, Giulia; Camerini, Andrea; Sperandi, Francesca; Colantonio, Ida; Metro, Giulio; Mazzoni, Francesca; Baldini, Editta; Veccia, Antonello; Bennicelli, Elisa; Cecilia Bettini, Anna; Tognetto, Michele; Ardizzoni, Andrea, An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016, «LUNG CANCER», 2025, 199, Article number: 108059 , pp. 1 - 8 [Scientific article]Open Access
Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Miroglio, C.; Montacci, E.; Ardizzoni, A.; Lauriola, M.; Romaniello, D., Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma, in: EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025, 2025(atti di: 2025 Annual Congress of the European Association for Cancer Research (EACR 2025), Lisbona, 16-19/6/2025) [Poster]
Francia, A.; Girone, C.; Filippini, D. M.; Querzoli, G.; Fermi, M.; Venturoli, S.; Degiovanni, A.; Castellano-Sanz, E.; Miroglio, C.; Montacci, E.; Ardizzoni, A.; Lauriola, M.; Romaniello, D., Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening, in: 17th ICHC Conference, 2025 | Abstracts, 2025(atti di: 17° Congresso Internazionale di Istochimica e Citochimica - ICHC, Rimini, 27-30/8/2025) [Poster]
Salvatore, V.; Viola, A.; Spezzano, A.; Aquilino, A.; Barili, L.; Caprino, M.; Floresta, M.; Momoli, G.; Romiti, A.; Scurria, G.; Sirna, M.; Paccapelo, A.; Nannini, M.; Ardizzoni, A.; Giostra, F., Diagnostic Accuracy of Procalcitonin in the Diagnosis of Sepsis in Cancer Patients Hospitalized for Infection, «CANCER REPORTS», 2025, 8, Article number: e70384 , pp. 1 - 7 [Scientific article]Open Access
Di Federico, A.; Wang, K.; Chen, M. F.; Barsouk, A. A.; Pagliaro, A.; Chen, L. N.; Ogliari, F. R.; Stockhammer, P.; Thawani, R.; Raslan, S.; Gariazzo, E.; Fusco, F.; Hambelton, G. M.; Citarella, F.; Meyer, D.; Aldea, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; Gelsomino, F.; Corassa, M.; Vokes, N. I.; Wang, X.; De Biase, D.; Abu Rous, F.; Areesawangkit, P.; Elghawy, O.; Cortellini, A.; Metro, G.; Ferrara, R.; Awad, M. M.; Pabani, A.; Murray, J. C.; Cappuzzo, F.; Garassino, M. C.; Dagogo-Jack, I.; Riely, G.; Grant, M.; Herzberg, B. O.; Ardizzoni, A.; Planchard, D.; Johnson, B. E.; Langer, C. J.; Offin, M.; Negrao, M. V.; Ricciuti, B., First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study, «THE LANCET ONCOLOGY», 2025, 26, pp. 1357 - 1369 [Scientific article]
Pecci, F.; Li, H.; Di Federico, A.; Wu, J.; Chen, H.; Gariazzo, E.; Mantuano, F.; Garbo, E.; Aldea, M.; Santo, V.; Gibbons, D.; Tran, H.; Paoloni, F.; De Almeida, G. R.; Metro, G.; De Giglio, A.; Gelsomino, F.; Wang, X.; Tiseo, M.; Rotow, J.; Ardizzoni, A.; Lee, J. J.; Awad, M. M.; Addeo, A.; Hong, L.; Negrao, M. V.; Janne, P. A.; Heymach, J. V.; Zhang, J.; Ricciuti, B.; Le, X., First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC, «CLINICAL CANCER RESEARCH», 2025, 31, pp. 4802 - 4813 [Scientific article]
De Giglio, A.; Zullo, L.; Di Federico, A.; Cani, M.; Aldea, M.; Soldato, D.; Dall'Olio, F. G.; Mantuano, F.; Sperandi, F.; Favorito, V.; Sadowska, A.; Hendriks, L. E. L.; Gorria, T.; Mezquita, L.; Tabbo, F.; Novello, S.; Gelsomino, F.; Besse, B.; Ardizzoni, A., Immunotherapy beyond progression combined with platinum-based chemotherapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 ≥50%, «ESMO OPEN», 2025, 10, Article number: 105897 , pp. 1 - 9 [Scientific article]
Di Federico, A.; Stumpo, S.; Mantuano, F.; De Giglio, A.; Lo Bianco, F.; Pecci, F.; Alessi, J. V.; Wang, X.; Sperandi, F.; Melotti, B.; Gelsomino, F.; Skoulidis, F.; Garassino, M. C.; Peters, S.; Awad, M. M.; Ardizzoni, A.; Ricciuti, B., Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis, «THE LANCET ONCOLOGY», 2025, 26, pp. 1443 - 1453 [Scientific article]
Di Federico, A; Hong, L; Elkrief, A; Thummalapalli, R; Cooper, A J; Ricciuti, B; Digumarthy, S; Alessi, J V; Gogia, P; Pecci, F; Makarem, M; Gandhi, M M; Garbo, E; Saini, A; De Giglio, A; Favorito, V; Scalera, S; Cipriani, L; Marinelli, D; Haradon, D; Nguyen, T; Haradon, J; Voligny, E; Vaz, V; Gelsomino, F; Sperandi, F; Melotti, B; Ladanyi, M; Zhang, J; Gibbons, D L; Heymach, J V; Nishino, M; Lindsay, J; Rodig, S J; Pfaff, K; Sholl, L M; Wang, X; Johnson, B E; Jänne, P A; Rekhtman, N; Maugeri-Saccà, M; Heist, R S; Ardizzoni, A; Awad, M M; Arbour, K C; Schoenfeld, A J; Vokes, N I; Luo, J, Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors, «ANNALS OF ONCOLOGY», 2025, 36, pp. 297 - 308 [Scientific article]
Dall'Olio, Filippo G; Zrafi, Wael; Roelants, Veronique; Ambrosini, Valentina; Fourquet, Aloyse; Mitea, Cristina; Passiglia, Francesco; Bauckneht, Matteo; Bonardel, Gerald; Conci, Nicole; Benitez, Jose Carlos; Arena, Vincenzo; Namour, Céline; Naigeon, Marie; Monnet, Isabelle; Beshiri, Kristi; Hoton, Delphine; Dursun, Safiye; Danlos, François Xavier; Argalia, Giulia; Aldea, Mihaela; Rovera, Guido; Derosa, Lisa; Iebba, Valerio; Gietema, Hester A; Gounant, Valerie; Lacroix, Valérie; Remon, Jordi; Gautheret, Daniel; Chaput, Nathalie; Job, Bastien; Kannouche, Patricia L; Velasco-Nuño, Monica; Zitvogel, Laurence; Cella, Eugenia; Chícharo De Freitas, José Reinaldo; Vasseur, Damien; Bettaieb, Mohamed Aymen; Tagliamento, Marco; Hendriks, Lizza; Italiano, Antoine; Planchard, David; Marabelle, Aurelien; Barlesi, Fabrice; Novello, Silvia; De Andreis, Desiree; Aboubakar Nana, Frank; Ardizzoni, Andrea; Zalcman, Gerard; Garcia, Camilo; Besse, Benjamin, Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates, «CLINICAL CANCER RESEARCH», 2025, 31, pp. 352 - 364 [Scientific article]
Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna, PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD), «JOURNAL OF TRANSLATIONAL MEDICINE», 2025, 23, Article number: 2 , pp. 1 - 20 [Scientific article]Open Access
Venturi, F.; Melotti, B.; Lambertini, M.; Alessandrini, A.; Ardizzoni, A.; Dika, E., Pembrolizumab-Induced Erosive Lichenoid Reaction in a Patient With Metastatic Lung Adenocarcinoma: A Case Report, «INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY», 2025, 8, pp. 175 - 177 [Scientific article]Open Access
de Marinis, Filippo; Ardizzoni, Andrea; Attili, Ilaria; Bonanno, Laura; Bria, Emilio; Cortinovis, Diego Luigi; Margaritora, Stefano; Mazzoni, Francesca; Mercadante, Edoardo; Morabito, Alessandro; Petrella, Francesco; Rea, Federico; Salvi, Rosario; Solli, Piergiorgio; Spaggiari, Lorenzo; Voltolini, Luca; Gridelli, Cesare, Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel Meeting, «CURRENT ONCOLOGY», 2025, 32, Article number: 110 , pp. 1 - 12 [Scientific article]Open Access
De Giglio, Andrea; De Biase, Dario; Favorito, Valentina; Maloberti, Thais; Di Federico, Alessandro; Zacchini, Federico; Venturi, Giulia; Parisi, Claudia; Gustavo Dall'Olio, Filippo; Ricciotti, Ilaria; Gagliano, Ambrogio; Melotti, Barbara; Sperandi, Francesca; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea, STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status, «LUNG CANCER», 2025, 199, Article number: 108058 , pp. 1 - 8 [Scientific article]Open Access
Girone, Cinzia; Mazzeschi, Martina; Sgarzi, Michela; Pagano, Federica; Romaniello, Donatella; Morselli, Alessandra; Montacci, Elisa; Borrelli, Francesco; Miroglio, Chiara; Francia, Anna; Timmermans, Jasmine; Ambrosi, Francesca; Fiorentino, Michelangelo; Sargenti, Azzurra; Rihawi, Karim; Ardizzoni, Andrea; Lauriola, Mattia, Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer, in: ABCD SIBBM 2024 National Ph.D. Meeting, 2024(atti di: National PhD Meeting ABCD, Bologna, 25-27/03/2024) [Poster]
